The 2nd annual Dubai International Conference on Infectious Diseases and Vaccination concludes today with the support of Ministry of Health and Prevention, European Society of Clinical Microbiology, Saudi Society of Clinical Microbiology and Infectious Diseases, Bahrain Medical Society, and Infection Prevention Society and organized by Maarefah Management.
Dr. Najiba Abdulrazzaq, Consultant Internist, Head of Medical Department, Al Baraha Hospital, Head of Infection Prevention and Control Central Committee, Ministry of Health and Prevention, UAE, said: “The status of the infection control in the UAE is quite excellent, most of the hospitals have a strong infection control programme and this has also been mandated in certain parts of the UAE like the Health Authority Abu Dhabi. Also, in Dubai Health Authority, the governmental hospitals have all been practicing infection control for more than 7 years, even further .In MOHAP hospital, infection prevention and control is mandated as well. Also to be noted that more than 50% of the hospitals in the UAE whether governmental or private are already internationally accredited and all these accrediting bodies require well-functioning infection control practice”.
“There are many challenges, however, these are general challenges that any country or any facility faces. The importance of hand hygiene compliance is really very crucial and though we are reporting a high compliance rate, still there are areas that we find challenging. Also, the prevalence and the emerging of multi-drug resistant organisms is an international problem as well as been faced locally. Preparedness for new emerging diseases is another difficulty that we face. Overcoming these challenges is difficult; it is very difficult to do it single-handedly on a facility level. It has to be done on a national level. This is what the ministry of health is doing currently. There are national committees from different parts of different health organisations in the country which have already drafted a plan for combatting infection control and antimicrobial resistance challenges”. added Dr. Najiba Abdulrazzaq.
Dr. Meral Akçay, Associate Professor of Virology, WHO-Coordinator of the National Influenza Reference Laboratory, Regional Disease Expert/Flu-Medical Manager, focused her presentation on Influenza burden and the importance of vaccination in some risk groups. “20-30% of Children (about 90 million), 5-10% of adults develop symptomatic influenza (500 million people), 2-3 million people develop severe disease, 250-500 thousand people die.” said Dr. Meral Akçay.
“Pregnancy is a risk factor for severe influenza even in women without underlying comorbidities, hospitalizations related to cardiopulmonary complications are 1.7 to 7.0 more frequent in pregnant women 1,4, risk increases as the pregnancy progresses 1,4.” added Dr. Meral Akçay.
The Dubai International Conference on Infectious Diseases & Vaccination covered scientific sessions, panel discussions and workshops. The 2nd edition witnessed great success with the participation of more than 400 attendees. The conference highlighted the topic of infectious diseases and vaccination with the goal of preventing and managing infections. The extremely comprehensive program encompassed numerous topics such as preventive medicine updates, HIV, vaccines, diagnostics advancements and clinical challenges, delivered over three days by 28 speakers.
About Maarefah Management:
Maarefah Management is a world-class events, training, and association management company that works closely with government institutions, industry bodies and professional associations to help individual’s career development to grow and sustain successful businesses. The company’s conferences and specialised training courses are developed by highly experienced scientific committees creating up-to-date scientific and technical programs tackling current and critical industry issues.
Source: Maarefah Management